Wall Street wants you to believe yesterday’s tech bloodbath is just about “AI spending concerns.” They’re dead wrong.Nvidia and Oracle stocks plummeted for the second straight day, sending shockwaves through the NASDAQ. Financial journalists scrambled to explain the selloff with their usual surface-level analysis. “Investors are worried about AI investment sustainability,” they proclaimed. “Oracle’s $300 billion OpenAI deal has people spooked about client concentration risk.”But here’s what Wall Street is n ...

Notable quantum computing firm D-Wave Quantum (QBTS) is experiencing a significant surge in its stock price as demand for quantum computing continues to grow. In May, the company launched its sixth-generation quantum system, the Advantage2. With more than 4,400 qubits, this system is designed to tackle complex computational problems that traditional systems cannot solve. Moreover, with a wide range of scientific and industrial use cases, Advantage2 stands as the most powerful quantum computer launched by ...

COLLEGE PARK, Md.--(BUSINESS WIRE)--IonQ (NYSE: IONQ), the leader in the quantum computing and networking industries, today announced it has achieved a record algorithmic qubit score of #AQ 64. This milestone was achieved on an IonQ Tempo system, three months ahead of schedule, establishing IonQ as the only company to reach #AQ 64 setting a new standard for quantum systems. #AQ benchmarks measure a quantum system's ability to run quantum algorithms of increasing complexity and size while mainta. ...

公司战略举措 - 公司董事会决议启动一项利用量子计算技术推进3D蛋白质建模的创新计划[1] - 该计划旨在通过前所未有的精度预测蛋白质结构及其与配体的相互作用来变革药物发现领域[1] - 公司将组建一个专门的研究团队，将量子计算算法整合到3D蛋白质建模中，目标是创造新的知识产权[3] - 公司将与量子计算和结构生物学领域的领先专家合作，以构建这些能力[3] - 公司预计将成立一家新的以色列全资子公司来运营该计划[3] 技术细节与目标 - 量子计算是一种利用量子力学原理进行计算的尖端技术，其计算能力远超传统计算机[3] - 与传统计算方法不同，量子计算可以更精确地模拟蛋白质的能量动力学，以更高的精度捕捉其复杂运动及与配体的相互作用[3] - 该计划专注于开发量子赋能工具，以准确预测蛋白质如何折叠成3D形状、模拟蛋白质如何与潜在药物相互作用，并通过提供高精度预测来加速新药发现[6] - 初步工作将集中于改进量子算法，以模拟蛋白质动力学和结合相互作用，目标应用于神经疾病和罕见疾病的药物发现[3] 公司背景与现有业务 - SciSparc Ltd 是一家专业的临床阶段制药公司，专注于开发基于大麻素药物的技术和资产组合[4] - 公司目前正在推进基于THC和/或非精神活性CBD的药物研发项目，包括治疗图雷特综合征、阿尔茨海默病和躁动的SCI-110，以及治疗自闭症谱系障碍和癫痫持续状态的SCI-210[4] - 公司在一家子公司中拥有控股权，该子公司的业务重点是在亚马逊平台上销售大麻籽油产品[4]

Key Points Quantum computing is widely seen as one of the next big frontiers in the evolution of AI. Small-cap Quantum Computing Inc. is turning heads, and the market has bid up the stock. As a result, the upstart tech company today sports a value that is largely speculative. 10 stocks we like better than Quantum Computing › When Nvidia (NASDAQ: NVDA) was founded in the 1990s, it was a niche chip designer. Its graphics processing units (GPUs) were engineered to enhance the visuals of video game ...

HSBC Holdings plc (NYSE: HSBC) announced on Thursday that it has produced the world’s first empirical evidence showing quantum computers can add measurable value in real-world financial markets. Partnering with International Business Machines Corp. (NYSE: IBM), the bank demonstrated that quantum-enhanced models improved prediction accuracy in algorithmic bond trading by as much as 34% compared with standard industry approaches. Algorithmic trading in corporate bonds depends heavily on models that rapidly ...

公司股价表现 - 公司股价年内迄今飙升约100% [1] - 股价上涨受到技术里程碑和政府合同的推动 [1] 技术进展 - 公司发布36量子位模块化系统Cepheus-1-36Q 其中位双量子位门保真度达到99.5% [1][4] - 该保真度较六个月前有2倍提升 [4] - 模块化4芯片组架构为超越当前限制的扩展提供路径 [4] - 公司目标在年底前推出100量子位系统 [4] 政府合同与行业支持 - 公司获得美国空军研究实验室一份价值580万美元的量子网络合同 [1][5] - 合同为期三年 公司将与荷兰初创公司QphoX合作开发超导量子网络节点 [5] - 行业另一纯业务公司IonQ已获得价值5450万美元的类似合同 [6] - 整个行业受益于联邦政府为维持对华量子优势而重新燃起的兴趣 [6] 财务与经营状况 - 公司上季度收入降至180万美元 低于一年前的310万美元 [2] - 公司每季度现金消耗接近4000万美元 [2] - 公司拥有5.71亿美元现金 提供了健康的运营缓冲 [7] 估值与市场预期 - 基于过往销售额的估值高达990倍 [2][7] - 该估值假设量子计算将在不久后从科学实验转变为商业现实 [2]

公司概况与定位 - 公司是一家专注于开发神经退行性疾病、神经发育障碍和神经精神疾病新型疗法的生物制药公司 [4] - 公司被列为当前最值得购买的十大无债务小型股之一 [1][4] 分析师评级与市场表现 - H C Wainwright于2025年9月11日重申对公司股票的“买入”评级，目标价为42美元 [2] - 公司股价当前交易价格远低于42美元的目标价，显示出显著的上行潜力 [3] 产品研发进展 - 公司于2025年9月9日宣布，其口服疗法blarcamesine在早期阿尔茨海默病患者的关键指标上显示出认知衰退减缓的效果 [3] - 积极的二期b/三期阿尔茨海默病试验数据是支撑分析师维持看涨立场的关键因素 [2] - 该数据增强了市场对公司精准医疗方法的信心 [3]

Vizsla Silver Corp. (NYSE:VZLA) is one of the 10 Best Debt Free Small Cap Stocks to Buy Now. BMO Capital Lifts Its PT on Vizsla Silver Corp. (VZLA) to $6.00, Keeps an ‘Outperform’ Rating Copyright: zimmytws / 123RF Stock Photo On September 8, 2025, BMO Capital lifted its price target on Vizsla Silver Corp. (NYSE:VZLA) from $5.00 to $6.00, keeping an ‘Outperform’ rating. This price revision follows the company’s strong recent momentum, with a 147.02% gain on a year-to-date basis. It also follows the com ...

A small group of quantum computing stocks have generated unbelievable returns over the past year.Quantum computing isn't as well known as artificial intelligence (AI), but a small group of these stocks has generated astounding returns in just a year or two.These companies are trying to build and commercialize the next innovation of the computer. Instead of using bits, the most basic unit of digital information and the foundational component of the computer, quantum computers use qubits that can process data ...